n-(4-(2-chlorophenyl)-6,7-dimethyl-3-quinolyl)-n'-(2,4-difluorophenyl)urea has been researched along with Adenocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, H; Ishikawa, E; Miki, N; Odaka, H; Sugiyama, Y; Tawada, H | 1 |
1 other study(ies) available for n-(4-(2-chlorophenyl)-6,7-dimethyl-3-quinolyl)-n'-(2,4-difluorophenyl)urea and Adenocarcinoma
| Article | Year |
|---|---|
TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters.
Topics: Adenocarcinoma; Animals; Anticholesteremic Agents; Bile; Carcinoma, Hepatocellular; Cholesterol; Colonic Neoplasms; Cricetinae; Dogs; Esterification; Humans; Intestinal Absorption; Intestinal Mucosa; Intestines; Liver; Liver Neoplasms; Male; Mesocricetus; Phenylurea Compounds; Rabbits; Rats; Rats, Sprague-Dawley; Sterol O-Acyltransferase; Tumor Cells, Cultured | 1995 |